Viewing Study NCT02318095


Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2025-12-29 @ 1:24 PM
Study NCT ID: NCT02318095
Status: COMPLETED
Last Update Posted: 2023-10-26
First Post: 2014-12-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Sponsor: Duke University
Organization: